Managing Gastrointestinal Side Effects During Antibiotic Treatment When to Consult Your Healthcare Provider Scientific References Frequently Asked Questions Understanding Wegovy and Antibiotics: Key Considerations Wegovy (semaglutide 2.4 mg) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed by the MHRA for weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with weight-related comorbidities
Feb 11, 2026 You are staring at a vial of tirzepatide, an insulin syringe in your other hand, and the label says 10mg/ml
Providers Primary Care Primary Care Primary Care Services Headaches Upper Respiratory Infections Urinary Tract Infections (UTIs) Sexually Transmitted Diseases Evaluation of Medical Problem(s) Coordinated Care & Referrals Medication Management Breast Cancer Screening Cervical Cancer Screening Colon Cancer Screening Lung Cancer Screening Prostate Cancer Screening Asthma and COPD Diabetes High Blood Pressure High Cholesterol Abscess Drainage Earwax Removal Minor Laceration Repair Mole and Skin Tag Removal COVID-19 Testing Flu Testing Sore Throat & Strep Throat Urinalysis Test Urine Pregnancy Tests Weight Loss Medications We offer compounded weight loss injections targeting GLP-1 and GIP receptors , with cash-pay options starting at $66/month
For those with diabetes, the drugs stimulate the pancreas production of insulin which brings down blood sugar to healthier levels
160 It is noteworthy that TMAOs role is not a one-way street
This requires annual reapplication and income documentation but provides completely free medication